Browse by author
Lookup NU author(s): Dr Reza Halse,
Emeritus Professor Steve Yeaman
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The regulation of glycogen synthesis and associated enzymes was studied in human myoblasts and myotubes maintained in culture. Both epidermal growth factor (EGF) and insulin stimulated glycogen synthesis approximately 2-fold, this stimulation being accompanied by a rapid and stable activation of the controlling enzyme glycogen synthase (GS). EGF also caused inhibition of glycogen synthase kinase 3 (GSK-3) and activation of the alpha isoform of protein kinase B (PKB) with the time-course and magnitude of its effects being similar to those induced by insulin. An inhibitor of the mitogen-activated protein (MAP) kinase pathway did not prevent stimulation of GS by EGF, suggesting that this pathway is not essential for the effect. A partial decrease in the fold activation of GS was, however, observed when p70(S6k) activation was blocked with rapamycin, suggesting a contribution of this pathway to the control of GS by either hormone. Wortmannin, a selective inhibitor of phosphatidylinositol 3'-kinase (PI-3 kinase) completely blocked the effects of both EGF and insulin in these cells. These results demonstrate that EGF, like insulin, activates glycogen synthesis in muscle, acting principally via the PKB/GSK-3 pathway but with a contribution from a rapamycin-sensitive component that lies downstream of PI-3 kinase.
Author(s): Halse R; Yeaman SJ; Rochford JJ; McCormack JG; Vandenheede JR; Hemmings BA
Publication type: Article
Publication status: Published
Journal: Journal of Biological Chemistry
Print publication date: 01/01/1999
ISSN (print): 0021-9258
Publisher: American Society for Biochemistry and Molecular Biology, Inc.
Altmetrics provided by Altmetric